Combination treatment of cancer with cetuximab and tetrac

Hung-Yun Lin (Inventor), Faith B. Davis (Inventor), Paul J. Davis (Inventor), Shaker A. Mousa (Inventor)

Research output: Patent


Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.
Original languageEnglish
Publication statusPublished - 2010


Dive into the research topics of 'Combination treatment of cancer with cetuximab and tetrac'. Together they form a unique fingerprint.

Cite this